Morgan Stanley
FENC icon

Morgan Stanley’s Fennec Pharmaceuticals FENC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.11M Sell
254,218
-42,395
-14% -$352K ﹤0.01% 4666
2025
Q1
$1.81M Sell
296,613
-49,763
-14% -$303K ﹤0.01% 4672
2024
Q4
$2.19M Buy
346,376
+197,914
+133% +$1.25M ﹤0.01% 4631
2024
Q3
$742K Buy
148,462
+46,377
+45% +$232K ﹤0.01% 5215
2024
Q2
$624K Buy
102,085
+27,995
+38% +$171K ﹤0.01% 5190
2024
Q1
$824K Sell
74,090
-80,188
-52% -$892K ﹤0.01% 5073
2023
Q4
$1.73M Buy
154,278
+111,818
+263% +$1.25M ﹤0.01% 4998
2023
Q3
$319K Sell
42,460
-18,198
-30% -$137K ﹤0.01% 5369
2023
Q2
$536K Buy
60,658
+2,485
+4% +$21.9K ﹤0.01% 5178
2023
Q1
$484K Buy
58,173
+12,797
+28% +$106K ﹤0.01% 5277
2022
Q4
$436K Buy
45,376
+9,314
+26% +$89.4K ﹤0.01% 5311
2022
Q3
$292K Sell
36,062
-4,279
-11% -$34.6K ﹤0.01% 5547
2022
Q2
$225K Sell
40,341
-9,839
-20% -$54.9K ﹤0.01% 5838
2022
Q1
$281K Buy
50,180
+9,171
+22% +$51.4K ﹤0.01% 5729
2021
Q4
$180K Buy
41,009
+26
+0.1% +$114 ﹤0.01% 6128
2021
Q3
$386K Sell
40,983
-2,447
-6% -$23K ﹤0.01% 5648
2021
Q2
$316K Buy
43,430
+2,453
+6% +$17.8K ﹤0.01% 5778
2021
Q1
$255K Sell
40,977
-17,052
-29% -$106K ﹤0.01% 5512
2020
Q4
$431K Buy
58,029
+14,206
+32% +$106K ﹤0.01% 5170
2020
Q3
$266K Buy
43,823
+21,070
+93% +$128K ﹤0.01% 4956
2020
Q2
$190K Buy
+22,753
New +$190K ﹤0.01% 5095
2020
Q1
Sell
-400
Closed -$3K 6608
2019
Q4
$3K Buy
400
+399
+39,900% +$2.99K ﹤0.01% 6457
2019
Q3
$0 Sell
1
-141
-99% ﹤0.01% 6671
2019
Q2
$1K Sell
142
-3,393
-96% -$23.9K ﹤0.01% 6534
2019
Q1
$17K Sell
3,535
-18,651
-84% -$89.7K ﹤0.01% 6055
2018
Q4
$142K Sell
22,186
-1,802
-8% -$11.5K ﹤0.01% 5418
2018
Q3
$196K Sell
23,988
-2,317
-9% -$18.9K ﹤0.01% 5460
2018
Q2
$275K Buy
26,305
+24,439
+1,310% +$255K ﹤0.01% 5410
2018
Q1
$23K Buy
1,866
+1,500
+410% +$18.5K ﹤0.01% 6095
2017
Q4
$4K Buy
+366
New +$4K ﹤0.01% 6360